Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer / Biondi, B; Palmieri, Ea; Pagano, L; Klain, M; Scherillo, G; Salvatore, Marco; Fenzi, G; Lombardi, G; Fazio, S.. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - STAMPA. - 88:(2003), pp. 211-214.

Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer.

Klain M;SALVATORE, MARCO;
2003

2003
Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer / Biondi, B; Palmieri, Ea; Pagano, L; Klain, M; Scherillo, G; Salvatore, Marco; Fenzi, G; Lombardi, G; Fazio, S.. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - STAMPA. - 88:(2003), pp. 211-214.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/417531
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact